Have a personal or library account? Click to login
Open Access
|Dec 2019

Abstract

Advanced heart failure (AHF) is the stage of heart failure (HF) refractory to maximal medical treatment, cardiac devices (CRT - cardiac resynchronization, ICD - implantable defibrillator) and surgical treatment. AHF has become of interest through the experience and favorable results of treatment by mechanical circulatory support (MCS) and cardiac transplant (CT). The article reviews the criteria for defining the AHF (2018 ESC statement), natural history and prognosis outside the advanced treatment forms. Evaluation of risk and prognostic factors is required before the decision of advanced therapy: clinical factors (HF severity and reduction of cardiorespiratory functional capacity), RV function, biological markers and elements of organ dysfunction, as well as reduction of tolerance to conventional medication.

Finally, the principles of treatment and the results of mechanical circulatory support and cardiac transplant are presented.

DOI: https://doi.org/10.2478/inmed-2019-0093 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Language: English
Page range: 47 - 57
Published on: Dec 30, 2019
Published by: Romanian Society of Internal Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2019 Leonida Gherasim, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.